Seastar Medical Holding Corp. 8-K Summary
Business Context and Reporting Period
Seastar Medical Holding Corp. (Nasdaq: ICU) filed a Current Report on Form 8-K on May 13, 2026. The filing announces the company's financial condition and results of operations for the three months ended March 31, 2026. The company is designated as an emerging growth company.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
No specific material changes versus the prior comparable period are detailed in the filing text. The report serves as a notification that the Q1 2026 results have been issued.
Guidance, Outlook, and Risks
The filing does not contain specific guidance, outlook, management commentary, or risk factors within the provided text. It explicitly states that the information in the press release (Exhibit 99.1) is "furnished" and not "filed" for purposes of Section 18 of the Exchange Act, meaning it is not subject to the liabilities of that section and shall not be deemed incorporated by reference into other filings.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 13, 2026) for actual Q1 2026 financial figures.
- Verify the company's cash position and burn rate given the lack of specific liquidity data in this summary.
- Confirm the status of the warrants (ICUCW) exercisable at $11.50 per share.
- Check for any forward-looking statements or updated guidance in the full press release.